CTP-543: Clinical Trials

4 trials of CTP-543, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 active not recruiting. 4 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 34Completed 3, Active not recruiting 1
Phase 21Active not recruiting 1

Follow CTP-543: new trials by email Literature Review of CTP-543 trials Research Report on CTP-543

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
European Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata
CTP-543 - Alopecia Areata
Phase 3CompletedSun Pharmaceutical Industries, Inc.4072021-10-192025-11-21
Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA2)
CTP-543 matching placebo, CTP-543 - Alopecia Areata
Phase 3CompletedConcert Pharmaceuticals5172021-06-102023-07-03
Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA1)
CTP-543 matching placebo, CTP-543 - Alopecia Areata
Phase 3CompletedConcert Pharmaceuticals7062020-11-232023-05-03
Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata
CTP-543 - Alopecia Areata
Phase 2 / Phase 3Active not recruitingSun Pharmaceutical Industries, Inc.10002019-04-042025-10-22

Conditions studied

Alopecia Areata (4)  ·  Alopecia (2)  ·  Hair Diseases (2)

Sponsors

Concert Pharmaceuticals (2)  ·  Sun Pharmaceutical Industries, Inc. (2)

Countries

Canada (3)  ·  France (3)  ·  Poland (3)  ·  Spain (3)  ·  United States (3)  ·  Germany (2)  ·  Hungary (2)

Results publications

PMID 39053611, PMID 41317911